Drug profile · INN
betaine anhydrous
AMVERSIO
betaine anhydrous (AMVERSIO) is a betaine-homocysteine s-methyltransferase substrate.
EMA: approved Alimentary tract and metabolism (A16) A16AA06
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — betaine anhydrous
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
betaine anhydrous (AMVERSIO) is a betaine-homocysteine s-methyltransferase substrate.
Key facts
INN betaine anhydrous
Brand AMVERSIO
Mechanism Betaine-homocysteine S-methyltransferase substrate
Target Betaine-homocysteine S-methyltransferase
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AA06
Mechanism of action
Betaine-homocysteine S-methyltransferase substrate
Primary target: Betaine-homocysteine S-methyltransferase
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is betaine anhydrous?
betaine anhydrous (AMVERSIO) is a betaine-homocysteine s-methyltransferase substrate.
What is the brand name for betaine anhydrous?
AMVERSIO is a marketed brand name for betaine anhydrous. Check FDA Drugs@FDA for the current US label holder and prescribing information.